Last Updated: 24 January 2022, 3:44PM (NZDT)
This information resource has been compiled to assist healthcare professionals with the management of neonates, infants, and children with suspected or confirmed COVID-19. This information is not intended to replace the recommendations or requirements of your local hospital policies.
This resource refers to the World Health Organization (WHO) guidelines.1 Please use the link within this resource to ensure you are accessing the WHO’s most up-to-date advice.
In most pediatric cases, there is no evidence to suggest therapy decisions should be changed. Care should be driven by the patient’s underlying physiological and clinical presentation in conjunction with current evidence-based respiratory-management strategies.
Patients requiring respiratory support due to COVID-19 illness will have a high viral load, and they pose a potential infection risk to healthcare professionals and other patients. All patients with confirmed or suspected COVID-19 illness must be managed with appropriate isolation and personal protective equipment (PPE) precautions. Refer to your hospital policy or the WHO guidelines.
The WHO guidelines suggest commencing oxygen therapy with nasal cannula or prongs is the preferred oxygen therapy-delivery method for young children as they may be better tolerated, and NHF may be considered in select patients with hypoxemic respiratory failure. All patients treated with NHF should be closely monitored for clinical deterioration.1
For data on aerosol dispersion, please visit Nasal High Flow Therapy COVID-19 Information.
Fisher & Paykel (F&P) Healthcare Nasal High Flow pediatric products#
The WHO guidelines note that in situations where mechanical ventilation might not be available, bubble nasal CPAP may be used for patients with severe hypoxemia and may be more readily available.1
For institutions where bubble CPAP is the current standard of care for newborn infants requiring respiratory support (for non-COVID-19 reasons), there are currently no recommendations to change clinical practice for the majority of neonatal patients.
With any bubble CPAP delivery system there are two main places where gases and potential aerosols are likely to leak: between the patient and the mask/prongs (patient leak), and where the air exits from the bubble CPAP generator (intentional leak).
F&P Healthcare Infant CPAP products#
F&P Healthcare Infant Resuscitation products#
When invasive ventilation is needed, delivering heated and humidified gas is widely recommended and practiced during invasive respiratory support.1
F&P Healthcare Infant Invasive Ventilation humidified circuits#
COVID‑19 patients, who are critically ill with severe respiratory disease, need high levels of humidity to assist with secretion management and mucus plugging.5 Heated humidification promotes efficient ventilation and gas exchange,6 and preserves optimal mucociliary function.7
For information about heated humidification for healthcare professionals managing COVID-19 patients, please visit Heated Humidification for Healthcare Professionals Managing COVID-19 Patients.
For further information on our pediatric product range, including specification sheets, instructions for use, and instructional videos, please visit our Infant Respiratory Care support page.
For further information on our F&P heated humidifiers and flow generators, please visit:
# Always refer to the user instructions supplied with the product for full setup instructions, warnings, cautions and contraindications. If a device setup is off-label, the user recognizes that it is not the approved setup of the device and that the responsibility for doing so is their own.
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
The AIRVO 2 family enables the transition of Optiflow therapy across critical, non-critical areas of the hospital and into the home.
Humidification for patients using a mask at home
Humidification for patients with a tracheostomy at home
A flow range of 2 to 60 L/min allows for use across the care continuum - from the most acute hospital environment to the home
With Optiflow you can independently titrate flow and FiO2 according to your patient's needs
Introducing F&P Evora™ Full, our new compact full face CPAP mask. Evora Full is minimal contact with full performance featuring our next generation of Dynamic Support Technology™
The adaptable, reliable and robust humidification system. Use with Evaqua™ 2 circuit technology to minimize condensate
Updates and support for healthcare professionals
Join our global team. View and apply for jobs with us.
Get in touch with our team, find a distributor or send an enquire.